|
Market Cap (3-Jul) $147,983,008 (477th) |
Close (30-Jun) $0.99 |
Volume (30-Jun) 1,077,429 |
Shortsold (19-Jun) 1,473,254 (0.38%) (338th) |
|
52w High $0.66 |
52w Low $0.165 |
P/E - |
EPS -0.05 |
PAR released this announcement to the ASX on 4 March 2022, 17:02. The announcement is marked as price sensitive, and is 10 page(s) in length and 175.5kb in size.
This announcement originated from JHX.
You can view all announcements from PAR and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAR was 4.752% short sold according to ASIC data. It was ranked the 31st most shorted stock on the ASX. It remains ranked 338th as of the latest reported data (19 June 2025).
| Other Recent Announcements from PAR | |
|---|---|
| Notification of cessation of securities - PAR | 29 June 2023, 16:43 |
| Primary and Secondary endpoints met in MPS I Trial | 6 June 2023, 12:28 |
| iPPS shows 3-year equivalent durability in OA Canine Study | 1 June 2023, 8:21 |
| S&P DJI Announces March 2022 Quarterly Rebalance | 4 March 2022, 17:02 |
| Amended Appendix 4D | 24 February 2022, 12:03 |
| Paradigm 1HY22 Key Activity Highlights | 24 February 2022, 10:15 |
| Half Yearly Report and Accounts | 24 February 2022, 9:47 |
You must be logged in to post a reply.
Paradigm Biopharmaceuticals 